Recognition and treatment of attention deficit-hyperactivity disorder in patients with treatment-resistant burning mouth syndrome: a retrospective case study
ADHD is frequently comorbid in patients with treatment-resistant BMS, and ADHD-targeted pharmacotherapy may help alleviate pain, cognitive dysfunction, and brain perfusion abnormalities. These findings suggest that ADHD screening, diagnosis, and multidisciplinary management involving psychiatrists could play a crucial role in optimizing clinical outcomes in patients with BMS.
Authors
- Tatsuya Ichinohe (ORCID: https://orcid.org/0000-0001-5793-3379)
- Satoshi Kasahara (ORCID: https://orcid.org/0000-0003-4736-9887)
- Naoko Sato (ORCID: https://orcid.org/0000-0001-5691-8089)
- Ko Matsudaira (ORCID: https://orcid.org/0000-0001-5584-5367)
- Toshimitsu Momose (ORCID: https://orcid.org/0000-0002-7566-400X)
- Ken‐ichi Fukuda (ORCID: https://orcid.org/0000-0003-3522-746X)
- Kanji Uchida (ORCID: https://orcid.org/0000-0001-9337-1916)
- Toshiyuki Handa (ORCID: https://orcid.org/0000-0002-9290-9865)
- M. Takahashi (ORCID: https://orcid.org/0000-0002-1953-7428)
- Kaori Takahashi
- Shin‐ichi Niwa
- Taito Morita
Institutions
- Fukushima Medical University (JP)
- Tokyo Dental College (JP)
- University of Tokyo Hospital (JP)
- National Institutes for Quantum Science and Technology (JP)
- Okayama Psychiatric Medical Center (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Frontiers in Pain Research
- Published
- 2025-04-23
- DOI
- https://doi.org/10.3389/fpain.2025.1536584
- Primary Topic
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00